BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

79

506235

ALEMBICLTD

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ALEMBIC LIMITED performance

Today’s low

Today’s high

₹ 99.50 ₹ 103.00
₹ 99.96

52 week low

52 week high

₹ 85.30 ₹ 169.00
₹ 99.96

Open Price

₹ 102.50

Prev. Close

₹ 101.50

Volume (Shares)

508438.00

Total traded value

₹ 508.23

Upper Circuit

₹ 121.80

Lower Circuit

₹ 81.20

info

ALEMBIC LIMITED Share Price Update

As of the latest trading session, ALEMBIC LIMITED share price is currently at ₹ 99.96, which is down by ₹ -1.54 from its previous closing. Today, the stock has fluctuated between ₹ 99.50 and ₹ 103.00. Over the past year, ALEMBIC LIMITED has achieved a return of 7.83 %. In the last month alone, the return has been 0.17 %. Read More...

ALEMBIC LIMITED fundamentals


  • Market cap (Cr)

    2,566.79

  • P/E Ratio (TTM)

    18.35

  • Beta

    1.37

  • Book Value / share

    33.04

  • Return on equity

    11.34%

  • EPS (TTM)

    5.44

  • Dividend yield

    2.40%

  • Net profit/quarter (Cr)

    25.69

info icon alternate text
  • Market cap (Cr)

    2,558.83

  • P/E Ratio (TTM)

    18.35

  • Beta

    1.24

  • Book Value / share

    33.04

  • Return on equity

    11.34%

  • EPS (TTM)

    5.44

  • Dividend yield

    2.40%

  • Net profit/quarter (Cr)

    25.69

info icon alternate text

ALEMBIC LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 55.97
Operating Expense 33.37
Net Profit 25.69
Net Profit Margin (%) 45.89
Earnings Per Share (EPS) 1.00
EBITDA 29.96
Effective Tax Rate (%) 4.32
Particulars SEP 2024 (Values in Cr)
Revenue 51.10
Operating Expense 35.82
Net Profit 76.60
Net Profit Margin (%) 149.90
Earnings Per Share (EPS) 2.98
EBITDA 83.97
Effective Tax Rate (%) 5.28
Particulars JUN 2024 (Values in Cr)
Revenue 49.08
Operating Expense 32.38
Net Profit 16.84
Net Profit Margin (%) 34.31
Earnings Per Share (EPS) 0.66
EBITDA 21.34
Effective Tax Rate (%) 9.41
Particulars MAR 2024 (Values in Cr)
Revenue 47.51
Operating Expense 25.84
Net Profit 20.68
Net Profit Margin (%) 43.52
Earnings Per Share (EPS) 0.81
EBITDA 25.33
Effective Tax Rate (%) 12.44
Particulars DEC 2023 (Values in Cr)
Revenue 37.94
Operating Expense 27.62
Net Profit 11.29
Net Profit Margin (%) 29.75
Earnings Per Share (EPS) 0.44
EBITDA 15.36
Effective Tax Rate (%) 9.89
Particulars MAR 2024 (Values in Cr)
Revenue 152.25
Operating Expense 104.16
Net Profit 92.89
Net Profit Margin (%) 61.01
Earnings Per Share (EPS) 3.62
EBITDA 110.85
Effective Tax Rate (%) 9.56
Particulars MAR 2023 (Values in Cr)
Revenue 123.16
Operating Expense 91.67
Net Profit 79.27
Net Profit Margin (%) 64.36
Earnings Per Share (EPS) 3.09
EBITDA 91.50
Effective Tax Rate (%) 6.74
Particulars MAR 2022 (Values in Cr)
Revenue 75.97
Operating Expense 67.78
Net Profit 85.71
Net Profit Margin (%) 112.82
Earnings Per Share (EPS) 3.34
EBITDA 102.01
Effective Tax Rate (%) 11.89
Particulars MAR 2021 (Values in Cr)
Revenue 72.30
Operating Expense 65.75
Net Profit 13.36
Net Profit Margin (%) 18.47
Earnings Per Share (EPS) 0.52
EBITDA 20.70
Effective Tax Rate (%) 19.12
Particulars MAR 2020 (Values in Cr)
Revenue 73.69
Operating Expense 73.48
Net Profit 93.55
Net Profit Margin (%) 126.95
Earnings Per Share (EPS) 3.64
EBITDA 97.19
Effective Tax Rate (%) 0.13
Particulars MAR 2024 (Values in Cr)
Book Value / Share 85.11
ROE % 4.36
ROCE % 4.83
Total Debt to Total Equity 0.00
EBITDA Margin 70.89
Particulars MAR 2023 (Values in Cr)
Book Value / Share 80.93
ROE % 3.52
ROCE % 3.80
Total Debt to Total Equity 0.00
EBITDA Margin 73.87
Particulars MAR 2022 (Values in Cr)
Book Value / Share 97.23
ROE % 3.60
ROCE % 4.09
Total Debt to Total Equity 0.00
EBITDA Margin 131.82
Particulars MAR 2021 (Values in Cr)
Book Value / Share 89.45
ROE % 0.54
ROCE % 0.68
Total Debt to Total Equity 0.00
EBITDA Margin 22.70
Particulars MAR 2020 (Values in Cr)
Book Value / Share 55.22
ROE % 7.08
ROCE % 7.09
Total Debt to Total Equity 0.00
EBITDA Margin 130.77
Particulars MAR 2024 (Values in Cr)
Book Value / Share 31.50
ROE % 11.34
ROCE % 12.47
Total Debt to Total Equity 0.01
EBITDA Margin 72.82
Particulars MAR 2023 (Values in Cr)
Book Value / Share 32.28
ROE % 8.60
ROCE % 9.21
Total Debt to Total Equity 0.00
EBITDA Margin 74.30
Particulars MAR 2022 (Values in Cr)
Book Value / Share 39.48
ROE % 9.31
ROCE % 10.55
Total Debt to Total Equity 0.00
EBITDA Margin 134.28
Particulars MAR 2021 (Values in Cr)
Book Value / Share 32.20
ROE % 1.47
ROCE % 1.84
Total Debt to Total Equity 0.00
EBITDA Margin 22.20
Particulars MAR 2020 (Values in Cr)
Book Value / Share 18.81
ROE % 20.89
ROCE % 20.77
Total Debt to Total Equity 0.00
EBITDA Margin 131.89
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.46
Total Assets 2328.77
Total Liabilities 2328.77
Total Equity 2185.56
Share Outstanding 256781828
Price to Book Ratio 2.66
Return on Assets (%) 11.53
Return on Capital (%) 12.24
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.89
Total Assets 2204.58
Total Liabilities 2204.58
Total Equity 2078.03
Share Outstanding 256781828
Price to Book Ratio 1.84
Return on Assets (%) 8.64
Return on Capital (%) 9.17
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.84
Total Assets 2631.95
Total Liabilities 2631.95
Total Equity 2496.58
Share Outstanding 256781828
Price to Book Ratio 1.83
Return on Assets (%) 8.43
Return on Capital (%) 8.89
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.57
Total Assets 2408.96
Total Liabilities 2408.96
Total Equity 2297.02
Share Outstanding 256781828
Price to Book Ratio 3.19
Return on Assets (%) 14.23
Return on Capital (%) 14.92
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 58.85
Total Assets 1470.72
Total Liabilities 1470.72
Total Equity 1418.04
Share Outstanding 256781828
Price to Book Ratio 1.90
Return on Assets (%) 22.37
Return on Capital (%) 23.21
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.19
Total Assets 945.87
Total Liabilities 945.87
Total Equity 808.75
Share Outstanding 256781828
Price to Book Ratio 2.66
Return on Assets (%) 9.82
Return on Capital (%) 11.36
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.79
Total Assets 948.14
Total Liabilities 948.14
Total Equity 828.98
Share Outstanding 256781828
Price to Book Ratio 1.84
Return on Assets (%) 8.36
Return on Capital (%) 9.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.59
Total Assets 1144.19
Total Liabilities 1144.19
Total Equity 1013.85
Share Outstanding 256781828
Price to Book Ratio 1.83
Return on Assets (%) 7.49
Return on Capital (%) 8.45
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.46
Total Assets 936.45
Total Liabilities 936.45
Total Equity 826.82
Share Outstanding 256781828
Price to Book Ratio 3.19
Return on Assets (%) 1.42
Return on Capital (%) 1.62
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 57.85
Total Assets 534.27
Total Liabilities 534.27
Total Equity 483.10
Share Outstanding 256781828
Price to Book Ratio 1.90
Return on Assets (%) 17.51
Return on Capital (%) 19.37
Particulars MAR 2024 (Values in Cr)
Net Income 102.68
Cash from Operations 22.11
Cash from Investing 25.83
Cash from Financing -48.19
Net change in Cash 0.32
Free Cash Flow 78.40
Particulars MAR 2023 (Values in Cr)
Net Income 86.79
Cash from Operations 45.37
Cash from Investing 7.29
Cash from Financing -46.38
Net change in Cash -0.23
Free Cash Flow 71.19
Particulars MAR 2022 (Values in Cr)
Net Income 97.85
Cash from Operations -8.70
Cash from Investing 18.84
Cash from Financing -5.81
Net change in Cash -4.71
Free Cash Flow 27.11
Particulars MAR 2021 (Values in Cr)
Net Income 17.04
Cash from Operations 0.05
Cash from Investing -34.86
Cash from Financing -15.36
Net change in Cash -52.41
Free Cash Flow 47.50
Particulars MAR 2020 (Values in Cr)
Net Income 93.16
Cash from Operations 8.06
Cash from Investing 56.72
Cash from Financing -6.40
Net change in Cash 56.84
Free Cash Flow 30.41
Particulars MAR 2024 (Values in Cr)
Net Income 102.71
Cash from Operations 23.67
Cash from Investing 22.60
Cash from Financing -47.77
Net change in Cash 0.15
Free Cash Flow 79.80
Particulars MAR 2023 (Values in Cr)
Net Income 84.99
Cash from Operations 41.12
Cash from Investing 11.29
Cash from Financing -46.07
Net change in Cash -0.09
Free Cash Flow 66.91
Particulars MAR 2022 (Values in Cr)
Net Income 97.27
Cash from Operations -13.22
Cash from Investing 22.66
Cash from Financing -5.65
Net change in Cash -4.85
Free Cash Flow 22.58
Particulars MAR 2021 (Values in Cr)
Net Income 16.51
Cash from Operations 0.83
Cash from Investing -35.14
Cash from Financing -15.26
Net change in Cash -51.52
Free Cash Flow 44.46
Particulars MAR 2020 (Values in Cr)
Net Income 93.68
Cash from Operations 6.96
Cash from Investing 56.79
Cash from Financing -6.39
Net change in Cash 55.87
Free Cash Flow 29.32
Company Name Price P/E P/B Market Cap 52 Week Low/High
ELPRO INTERNATIONAL LTD. 80.08 16.41 0.66 1357.19 62.30 / 147.70
FORBES & COMPANY LTD. 357.00 17.12 2.49 460.53 264.35 / 787.95
GOLDEN TOBACCO LIMITED 40.25 13.37 -0.33 70.88 36.00 / 60.90
PENINSULA LAND LIMITED 28.70 54.15 3.44 929.88 21.05 / 78.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
SANATHNAGAR ENTERPRISES LIMITE 37.97 0.00 -0.95 11.96 25.12 / 87.55
BARODA RAYON CORPORATION LTD. 130.05 19.21 0.86 297.96 120.30 / 215.00
ELPRO INTERNATIONAL LTD. 80.08 22.06 0.70 1357.19 62.30 / 147.70
FORBES & COMPANY LTD. 357.00 16.20 3.20 460.53 264.35 / 787.95

ALEMBIC LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
99.96 -1.51 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 101.80
  • 26 Days 101.70
  • 10 Days 102.30
  • 50 Days 103.50
  • 12 Days 102.30
  • 100 Days 109.80
  • 20 Days 101.90
  • 200 Days 114.10
102.23 PIVOT

First Support

100.47

First Resistance

103.27

Second Support

99.43

Second Resistance

105.03

Third Support

97.67

Third Resistance

106.07

RSI

46.78

ADX

24.20

MACD

0.59

Williams % R

-60.40

Commodity Channel Index (CCI)

-32.78

Date

2025-04-30

Week

197498.00

Same Day

153810.00

Month

251725.00

1 Year

1.37

3 Year

1.16

Over 1 Month

0.17%

down

Over 1 Year

7.83%

down

Over 3 Months

-13.45%

down

Over 3 Years

8.80%

down

Over 6 Months

-20.66%

down

Over 5 Years

14.67%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

ALEMBIC LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
27.41%
Promoter Holdings
70.88%
FII
1.65%
DII
0.05%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Nirayu Limited 1.61915052E8 (63.06%) Shareholding of Promoter and Promoter Group
Chirayu Ramanbhai Amin 8317644.0 (3.24%) Shareholding of Promoter and Promoter Group
Malika Chirayu Amin 7678954.0 (2.99%) Shareholding of Promoter and Promoter Group
Shaunak Chirayu Amin 1932651.0 (0.75%) Shareholding of Promoter and Promoter Group
Pranav Chirayu Amin 1932411.0 (0.75%) Shareholding of Promoter and Promoter Group
Samira Pranav Amin 57410.0 (0.02%) Shareholding of Promoter and Promoter Group
Ranvir Pranav Amin 57410.0 (0.02%) Shareholding of Promoter and Promoter Group
Naintara Shaunak Amin 57410.0 (0.02%) Shareholding of Promoter and Promoter Group
Inaaya Shaunak Amin 57410.0 (0.02%) Shareholding of Promoter and Promoter Group
Chirayu Ramanbhai Amin Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Krupa Shaunak Amin 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Barkha Pranav Amin 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Tishya Udit Amin 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Udit Chirayu Amin 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Cra Family Trust (chirayu Ramanbhai Amin) 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Satori Trust (chirayu Ramanbhai Amin) 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Grace Star Trust (shaunak Chirayu Amin) 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Gallup Trust (pranav Chirayu Amin) 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Laksh Trust (chirayu Ramanbhai Amin) 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Bhailal Amin General Hospital (chirayu Ramanbhai Amin) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Uday Education Society (biniti Trivedi) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Virsad Family Trust (pranav Chirayu Amin) 200.0 (0.0%) Shareholding of Promoter and Promoter Group
Laburnum Family Trust (chirayu Ramanbhai Amin) 200.0 (0.0%) Shareholding of Promoter and Promoter Group
Ujjval Vidyalaya (malika Chirayu Amin) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Utkarsh Vidyakendra (malika Chirayu Amin) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Arogyavardhini Society (malika Chirayu Amin) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Vidyanidhi Trust (malika Chirayu Amin) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Viramya Packlight Llp 1800.0 (0.0%) Shareholding of Promoter and Promoter Group
Shreno Engineering Limited 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Shreno Limited 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Alembic City Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Alembic Pharmaceuticals Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Shreno Publications Limited 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Paushak Limited 1525.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

ALEMBIC LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
03 Aug 2023 2.2 Final 03 Aug 2023 Equity shares
12 Sep 2022 1.8 Final 13 Sep 2022 Equity shares
29 Jul 2021 0.2 Final 31 Jul 2021 Equity shares
29 Jul 2020 0.6 Final 31 Jul 2020 Equity shares
18 Sep 2019 0.2 Final 20 Sep 2019 Equity shares
27 Jul 2018 0.2 Final 31 Jul 2018 Equity shares
19 Jul 2017 0.2 Final 21 Jul 2017 Equity shares
01 Aug 2016 0.15 Final 03 Aug 2016 Equity shares
03 Aug 2015 0.15 Final 05 Aug 2015 Equity shares
04 Aug 2014 0.15 Final 06 Aug 2014 Equity shares
26 Aug 2013 0.2 Final 28 Aug 2013 Equity shares
21 Jul 2010 0.5 Final 23 Jul 2010 Equity shares
17 Jul 2009 0.4 Final 21 Jul 2009 Equity shares
17 Jul 2008 1.5 Final 21 Jul 2008 Equity shares
13 Aug 2007 1.0 Final 16 Aug 2007 Equity shares
16 Aug 2005 0.0 Final 18 Aug 2005 Equity shares
Ex-Date Ex-Bonus Ratio
30 Sep 2013 27 Sep 2013 1:1
27 Mar 2004 25 Mar 2004 2:1
Ex-Date Old FV NEW FV Record Date
26 Sep 2006 10.0 2.0 04 Oct 2006
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
03 Aug 2023 2.2 Final 03 Aug 2023 Equity shares
12 Sep 2022 1.8 Final 13 Sep 2022 Equity shares
29 Jul 2021 0.2 Final 31 Jul 2021 Equity shares
29 Jul 2020 0.6 Final 31 Jul 2020 Equity shares
18 Sep 2019 0.2 Final 20 Sep 2019 Equity shares
27 Jul 2018 0.2 Final 31 Jul 2018 Equity shares
19 Jul 2017 0.2 Final 21 Jul 2017 Equity shares
01 Aug 2016 0.15 Final 03 Aug 2016 Equity shares
03 Aug 2015 0.15 Final 05 Aug 2015 Equity shares
04 Aug 2014 0.15 Final 06 Aug 2014 Equity shares
26 Aug 2013 0.2 Final 28 Aug 2013 Equity shares
21 Jul 2010 0.5 Final 23 Jul 2010 Equity shares
17 Jul 2009 0.4 Final 21 Jul 2009 Equity shares
17 Jul 2008 1.5 Final 21 Jul 2008 Equity shares
13 Aug 2007 1.0 Final 16 Aug 2007 Equity shares
16 Aug 2005 0.0 Final 18 Aug 2005 Equity shares
Ex-Date Ex-Bonus Ratio
30 Sep 2013 27 Sep 2013 1:1
27 Mar 2004 25 Mar 2004 2:1
Ex-Date Old FV NEW FV Record Date
26 Sep 2006 10.0 2.0 04 Oct 2006

ALEMBIC LIMITED Share Price

Alembic Limited is one of the India's most experienced manufactures of bulk drugs and pharmaceuticals formulation in human and animal healthcare. The Company operates primarily in three lines of business, manufacture of Bulk Drugs, Real Estate and Power Generation through Windmills and Co-gen Power Plant which is presently used for captive consumption for the operation of the Bulk Drugs Manufacturing plant at Vadodara. The Company is dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business.

The company manufacture pharmaceuticals and chemicals, bulk drugs (penicillin and other antibiotics) and formulations. It works manufacturing facilities at Vadodara in Gujarat and Solan in Himachal Pradesh.

Alembic Limited was incorporated in year 1907 with the name 'Alembic Chemical Works Company Limited' in Vadodara to manufacture tinctures and alcohol. They started to manufacture cough syrup, vitamins, tonics and sulphur durgs in 1940. In 1961, they inaugurated the 'Pencillin Palnt'. In 1968, they started to manufacture Streptomycin.

In the 1971, they manufactured Erythromycin using expertise from Eli Lilly, USA and in the year 1972, they launched Althrocin, a brand of Erythromycin. In year 1997, Althrocin become top selling brand in India. In the year 2001, they started to manufacture Cephalosporin C. In June 2001, the company formed a wholly owned subsidiary company named Alembic Europe Pvt Ltd in UK.

In the year 2005, the company has launched ZERO, a new generation, no calories, Sucralose Based Sugar Substitute which gave entry for the company into the high-growth lifestyle OTC product segment. In May 2005, the generic alliances and API division were merged to form an independent SBU.

The company has set up a formulation manufacturing facility at Baddi in Himachal Pradesh with a production capacity 900 million tablets and 600 million liquid oral bottles annually. During the year 2005-06, the company has increased the installed capacity of Tablets & Capsules and Oral Preparation & Ointments by 595 Million Nos and 720 MT respectively.

During the year 2005-06, the company acquired API Plant at Karakhadi in Vadodara. In the year 2007, the company acquired the Non-Oncology Business of Dabur Pharma Ltd. Also in the same year, they entered into a licensing agreement for its Novel Drug Delivery Platform for Keppra XR with UCB Belgium. During the year 2007-08, the company acquired the API manufacturing facility of Nirayu Pvt Ltd at Panelav near Vododara.

The Company formed a wholly owned subsidiary viz. Alembic Global Holding SA in Neuchatel, Switzerland in 2009. The 'Pharmaceutical Undertaking' of the Company demerged and the same got transferred to Alembic Pharmaceuticals Limited with effect from Appointed date i.e. 1st April, 2010. The maiden real estate project -'Samsara' was completed in 2014.

The Company launched second real estate project, VEDA in 2015-16. It further launched two API's in 2017. During year 2017-18, Alembic City Limited (formerly known as Alembic Exports Limited) became wholly-owned subsidiary of the Company.

During 2018-19, the Composite Scheme of Arrangement comprising of transfer and vesting of the Identified Real Estate Undertaking of Alembic Limited (the Company / the First Demerged Company) into Shreno Limited (the First Transferee Company/ the Second Demerged Company) and transfer and vesting of Engineering Division and Investment Division of Shreno Limited into Nirayu Private Limited (the Second Transferee Company) and their respective shareholders with effect from the Appointed Date i.e. 1st November, 2018 was sanctioned by the Hon'ble National Company Law Tribunal, Ahmedabad Bench (NCLT') vide its order dated 26th July, 2019. Accordingly, Scheme was made effective from 26th July, 2019.

The Company launched a residential project VEDA - II during 2020.

Parent organization Alembic Group
NSE symbol ALEMBICLTD
Founded 1907
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Alembic Ltd?

Answer Field

The share price of Alembic Ltd for NSE is ₹ 99.96 and for BSE is ₹ 99.65.

What is the Market Cap of Alembic Ltd?

Answer Field

The market cap of Alembic Ltd for NSE is ₹ 25,66.79 Cr. and for BSE is ₹ 25,58.83 Cr. as of now.

What is the 52 Week High and Low of Alembic Ltd?

Answer Field

The 52 Week High and Low of Alembic Ltd for NSE is ₹ 169.00 and ₹ 85.30 and for BSE is ₹ 169.00 and ₹ 85.55.

How to Buy Alembic Ltd share?

Answer Field

You can trade in Alembic Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Alembic Ltd?

Answer Field

The 1 year returns on the stock has been 7.83%.

What is the Current Share Price of Alembic Ltd?

Answer Field

Alembic Ltd share price is for NSE ₹ 99.96 & for BSE ₹ 99.65 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Alembic Ltd Share?

Answer Field

The market cap of Alembic Ltd for NSE ₹ 25,66.79 & for BSE ₹ 25,58.83 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Alembic Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Alembic Ltd share is 18.35.

What is the PB ratio of Alembic Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Alembic Ltd share is 33.04.

How to Buy Alembic Ltd Share?

Answer Field

You can trade in Alembic Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Alembic Ltd Share on Bajaj Broking App?

Answer Field

To buy Alembic Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Alembic Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|